Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Kidney Med
Autori principali: Shima, Hisato, Okamoto, Takuya, Tashiro, Manabu, Inoue, Tomoko, Masaki, Chiaki, Tada, Hiroaki, Takamatsu, Norimichi, Kawahara, Kazuhiko, Okada, Kazuyoshi, Doi, Toshio, Minakuchi, Jun, Kawashima, Shu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380391/
https://ncbi.nlm.nih.gov/pubmed/32734188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.03.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi